Fate Therapeutics (FATE) SEC Filings & 10K Form

$4.08
+0.18 (+4.62%)
(As of 05/10/2024 08:54 PM ET)

Recent Fate Therapeutics SEC Filings

DateFilerForm TypeView
05/09/2024
8:01 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
04/26/2024
3:16 PM
Fate Therapeutics (Filer)
Form ARS
03/25/2024
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
03/20/2024
4:30 PM
Fate Therapeutics (Filer)
Form 424B5
03/04/2024
12:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
5:06 PM
Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:01 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
12:44 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/22/2024
12:46 PM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:29 PM
Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:35 PM
Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:39 PM
Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
11:17 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Form SC 13D/A
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
12/18/2023
10:40 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
11/09/2023
10:57 AM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
4:10 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
3:44 PM
Fate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/10/2023
10:16 AM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/01/2023
4:29 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
9:40 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/06/2023
4:18 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
4:19 PM
Fate Therapeutics (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
2:16 PM
Fate Therapeutics (Subject)
Powl Brian T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2023
11:57 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
10:08 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
6:22 PM
Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
6:22 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
7:52 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FATE) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners